| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
132.54(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $539.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,506 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,439,266 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
5 |
6 |
7 |
8 |
| Total Sell Transactions |
6 |
8 |
10 |
15 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2020-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
797 |
797 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2020-12-01 |
4 |
D |
$313.90 |
$4,634,420 |
D/D |
(14,764) |
53,594 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-11-16 |
4 |
AS |
$330.77 |
$1,946,456 |
D/D |
(5,834) |
32,642 |
|
11% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-11-16 |
4 |
OE |
$100.77 |
$214,905 |
D/D |
1,708 |
38,476 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2020-11-09 |
4 |
S |
$330.75 |
$396,569 |
D/D |
(1,199) |
3,229 |
|
-9% |
|
| Zielinski Thomas C |
EVP & General Counsel |
• – – |
2020-11-03 |
4 |
S |
$292.07 |
$2,680,917 |
D/D |
(9,175) |
17,910 |
|
-17% |
|
| Zielinski Thomas C |
EVP & General Counsel |
• – – |
2020-11-03 |
4 |
OE |
$232.04 |
$439,252 |
D/D |
1,893 |
19,803 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-10-15 |
4 |
AS |
$287.58 |
$1,703,238 |
D/D |
(5,834) |
36,768 |
|
2% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-10-15 |
4 |
OE |
$100.77 |
$470,294 |
D/D |
4,667 |
42,602 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-10-09 |
4 |
AS |
$295.00 |
$344,265 |
D/D |
(1,167) |
37,935 |
|
-1% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-10-02 |
4 |
AS |
$280.00 |
$1,306,760 |
D/D |
(4,667) |
39,102 |
|
6% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-10-02 |
4 |
OE |
$89.44 |
$446,784 |
D/D |
4,667 |
43,769 |
|
- |
|
| Alter Jeffrey D. |
EVP, IngenioRx & Anthem Health |
• – – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,746 |
2,746 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• – – |
2020-09-04 |
4 |
D |
$276.22 |
$32,594 |
D/D |
(118) |
12,073 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2020-07-02 |
4 |
D |
$267.00 |
$61,677 |
D/D |
(231) |
18,181 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-06-08 |
4 |
AS |
$300.00 |
$4,200,300 |
D/D |
(14,001) |
39,102 |
|
-3% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-06-08 |
4 |
OE |
$89.44 |
$1,045,140 |
D/D |
11,421 |
53,103 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2020-06-08 |
4 |
S |
$297.74 |
$162,268 |
D/D |
(545) |
4,400 |
|
3% |
|
| Zielinski Thomas C |
EVP & General Counsel |
• – – |
2020-06-08 |
4 |
S |
$297.70 |
$1,892,777 |
D/D |
(6,358) |
25,192 |
|
3% |
|
| Peru Ramiro G |
Director |
– • – |
2020-06-08 |
4 |
AS |
$300.00 |
$330,600 |
D/D |
(1,102) |
10,770 |
|
-3% |
|
| Dixon Robert L Jr |
Director |
– • – |
2020-05-27 |
4 |
S |
$284.59 |
$313,618 |
D/D |
(1,102) |
9,568 |
|
-3% |
|
| Clark R Kerry |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
7,261 |
|
- |
|
| Tallett Elizebeth E |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
8,513 |
|
- |
|
| Hill Julie A |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
32,521 |
|
- |
|
| Hay Lewis III |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
699 |
9,128 |
|
- |
|
123 Records found
|
|
Page 3 of 5 |
|
|
1.35 (0.26%) 
